Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial.
Thais Rodrigues GalacheMarcelo GalacheMichelle Mota SenaChristiane PavaniPublished in: BMJ open (2023)
ClinicalTrials.gov Registry (NCT05326997).